Epicyte Pharmaceutical, Inc.
is a biopharmaceutical company focused on the discovery and
development of therapeutics to treat inflammatory and infectious
diseases. The company’s proprietary technology for producing
antibodies in plants allows Epicyte to address an unmet need –
making antibody treatments for common infectious diseases in
large enough quantities for widespread use. High production
costs associated with traditional methods for producing
antibodies have limited their use as a disease treatment.
Epicyte’s technology for growing antibodies in plants is
scalable and cost effective.
|